MTSL Issue 814

 Comments Off on MTSL Issue 814
Nov 012015
 
MTSL Issue 814

Issue No. 814 (dated 10/29/15) of the Medical Technology Stock Letter from BioInvest includes the Biotech Sector Analysis as well as updates from the following companies found in the MTSL Portfolio: #ALKS, #CBMG, #IMGN, #MDCO, #NVAX, #OGXI, #PCRX, #SGMO, #XON

MTSL Issue 805

 Comments Off on MTSL Issue 805
Jun 122015
 
MTSL Issue 805

Issue No. 805 (dated 6/11/15) of the Medical Technology Stock Letter from BioInvest includes the Biotech Sector Analysis as well as updates from the following companies found in the MTSL Portfolio: #ANTH, #CBMG, #IMGN, #INCY, #ISIS, #MDCO, #NKTR, #OGXI, #ZIOP

Biotech Fund Managers – What The Pros Do Every Year

 Comments Off on Biotech Fund Managers – What The Pros Do Every Year
Aug 222014
 
Biotech Fund Managers - What The Pros Do Every Year

Biotech Fund Managers – What The Pros Do Every Year  August 21, 2014   The Medical Technology Stock Letter (“MTSL”) prides itself on identifying exciting small companies that will become leaders in their respective fields over time. We emphasize “over time” because that is the nature of drug development and compounded returns of successful biotech […]

A BRIEF IMMUNE-ONCOLOGY UPDATE

 Comments Off on A BRIEF IMMUNE-ONCOLOGY UPDATE
Jun 202014
 
A BRIEF IMMUNE-ONCOLOGY UPDATE

A BRIEF IMMUNE-ONCOLOGY UPDATE June 12, 2014 ASCO 2014 – Immune Oncology Rises to the Top – As many expected, immune oncology (I-O) was all the rage at the recently concluded American Society of Clinical Oncology (ASCO) meeting.  While it is widely acknowledged that before ASCO, Bristol was the leader in the space followed by […]